Previously Unconnected Molecular Networks...
Inflammatory signaling blocks NUMB’s ability to deaden NOTCH1-driven tumor development
MD Anderson News Release
HOUSTON — An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Working in...
Sir Richard Branson, Miles O’Brien Interview to Benefit UT MD...
Branson, O’Brien available for media questions at 1:30-2 p.m. press conference immediately following program. Contact MD Anderson...
UT MD Anderson Releases Annual Holiday Artwork Created By Young...
Prognostic Model Developed for MDS...
Identification of varied survival prospects may guide care for patients whose myelodysplastic syndrome stems from radiation, chemotherapy
MD Anderson News Release 12/13/11
A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer Center report...
AML Patients Have High Response Rate with Vorinostat Added to...
National Phase III clinical trial will test histone deacetylase inhibitor with frontline therapy
MD Anderson News Release...
B Cell Receptor Inhibitor Causes Chronic Lymphocytic Leukemia...
PCI-32765 applies molecularly aimed attack to disease usually treated with chemotherapy combinations
MD Anderson News...
Combination of Everolimus and Exemestane Improves Progression-Free...
Holiday Leftovers: Smart Tips to Control Overeating
UT MD Anderson experts share advice on how to avoid holiday weight gain
MD Anderson News Release 12/6/11
Holiday...
MD Anderson A Conversation With a Living Legend in Dallas Honors...
Dallas 'Conversation' With Miles O'Brien to Raise Funds for Cancer Research, Patient Care
MD Anderson News Release 12/...